A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
Clinical trial NCT05801835 · UNKNOWN
Trial details
- NCT number
- NCT05801835
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2025-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.